← Evidence map

ArticleReports (MDPI)2026

Successful Treatment of Persistent and Relapsing COVID-19 with Ensitrelvir in a Patient with Obinutuzumab-Induced Long-Term B-Cell Depletion: A Case Report.

Yoshitaka Haino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Successful Treatment of Persistent and Relapsing COVID-19 with Ensitrelvir in a Patient with Obinutuzumab-Induced Long-Term B-Cell Depletion: A Case Report. | OpenQuestion